Comment on: BSR/BHPR guideline for disease-modifying anti-rheumatic drug (DMARD) therapy in consultation with the British Association of Dermatologists

Rheumatology (Oxford). 2008 Oct;47(10):1591; author reply 1591. doi: 10.1093/rheumatology/ken322. Epub 2008 Aug 1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy
  • Drug Eruptions / etiology*
  • Drug Monitoring / methods
  • Humans
  • Practice Guidelines as Topic*

Substances

  • Antirheumatic Agents